iiinova — where your digital self keeps evolving

Jamie Finlay

@jamiefinlay.bsky.social

24 followers 11 following 8 posts

He/Him. Heart Failure Nurse interested in Education, Emerging Technologies & Cardiac Rehab

Posts Replies Media

Reposted by Jamie Finlay

The Pumping Marvellous Foundation @pumpingmarvellous.bsky.social · 31/12/2024

Nick Hartshorne-Evans the Founder and CEO of the Pumping Marvellous Foundation, the UK’s heart failure charity based in Preston, has been named in the New Year’s Honours list. Read more here pumpingmarvellous.org/new-year-honou… #NewYearsHonours

pumpingmarvellous.org

174

Jamie Finlay @jamiefinlay.bsky.social · 22/11/2024

Great discussion from an amazing panel regarding #weightloss #obesity #BSHAM2024

031

Jamie Finlay @jamiefinlay.bsky.social · 22/11/2024

Some great advice from the #dieticians regarding obesity and helping patients lose weight 🏃🥗👂#BSHAM2024

011

Jamie Finlay @jamiefinlay.bsky.social · 21/11/2024

Last up today at the #BSHAM2024 🫀vs🫘 - I know who I have my money on (not biased as a cardiology nurse🤣)

011

Jamie Finlay @jamiefinlay.bsky.social · 21/11/2024

Huge Congratulations to the Aneurin Bevan Health boards #heartfailure #consultantnurse Linda Edmunds MBE for her nomination of the #lindabloomaward at the #BSHAM2024. Thanks to Gwent #cardicrehab their support 💚

010

Jamie Finlay @jamiefinlay.bsky.social · 21/11/2024

Ready for the #BSHAM2024 - Our #heartfailure Posters are up from the #ABUHB in #wales … and I have had coffee

121

Jamie Finlay @jamiefinlay.bsky.social · 20/11/2024

Down in London for the #bsh2024; ready for 2 days of #heartfailure related learning🫀

000

Reposted by Jamie Finlay

Eric Topol @erictopol.bsky.social · 16/11/2024

Another GLP-1 drug success. Tirzepatide in heart failure with preserved ejection fraction (HFpEF) with longer term follow-up than 2 previous trials with semaglutide nejm.org/doi/full/10.... in people with BMI >30; no data yet for HFpEF in people without obesity

nejm.org

Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity | NEJM

Obesity increases the risk of heart failure with preserved ejection fraction. Tirzepatide, a long-acting agonist of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor...

324238